NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Acorn Bioventures

Acorn Bioventures

New York City, New Yorkacornbioventures.com

Overview

Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire specturm forom seeed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc. Management teams of our portfolio companies are our long-term partners and we are proud to be part of the entreprenurial spirit and pionerring spirit in biotech.

Year Founded

2017

Portfolio Companies

10

Investments

Acorn Bioventures investments
CompanyDateStageLead
CybinMar 2026Private PlacementCo-investor
Neuron23Jun 2025Series DCo-investor
OnKure TherapeuticsOct 2024Private PlacementCo-investor
Acrivon TherapeuticsApr 2024PIPECo-investor
NeurosterixApr 2024Series ACo-investor

Key People

Anders Hove

Partner and Founder

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.